The FTSE 100 made a positive start, climbing 61 points to 7,270. Miners Glencore, Rio Tinto and Antofagasta lead the way on London’s blue chip-index.
Russia missed a deadline to pay some Taiwanese investors its international bonds. It is the first time in over a century – since the Bolshevik revolution in 1917 – it is in foreign debt default.
G7 leaders, including Johnson and Biden, have made detailed plans for US$600bn in funding for the developing world. The move, which will rival China’s multi-trillion-dollar initiative, will help improve infrastructure in low and middle-income nations.
Wise said it continued to support its chief executive Kristo Kärmann while he is being investigated by the City watchdog over a deliberate tax default, which the board said it is taking “very seriously”. After HMRC published a list of business and individual tax defaults, the board of the international payments company carried out an investigation with support from external lawyers.
MGC Pharmaceuticals hailed the ‘big leap forward’ made by researchers carrying out a preclinical assessment of one of its lead assets. Preliminary results showed CimetrA has a wide-ranging application as an anti-inflammatory treatment.
ImmuPharma said partner Avion moved to the final stage of the US regulatory process ahead of a new phase III trial of Lupuzor. Lupuzor is a treatment for the autoimmune disorder lupus.